This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Treatment of osteoporosis in breast cancer sufferers

Authoring team

Hormone replacement therapy is relatively contraindicated in women with a history of breast cancer. After appropriate counselling they may opt to take HRT.

Tamoxifen however will offer some preservation of lumbar spine bone density and there is some evidence to suggest that these patients are at a lower risk of osteoporosis.

Raloxifene may have a role, since it has been shown to lead to a decreased incidence of oestrogen recptor positive breast tumours.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.